Results of Operations
We have neither engaged in any operations nor generated any operating revenues to date. Our only activities through June 30, 2022 were organizational activities, those necessary to prepare for the Initial Public Offering, and identifying a target company for a Business Combination. We will not generate any operating revenues until after the completion of our Business Combination, at the earliest. We generate non-operating income in the form of interest income on cash and marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended June 30, 2022, we had net income of $12,656,038, which consists of change in fair value of warrant liabilities of $13,590,933 and interest income on cash and marketable securities held in the Trust Account of $435,423, offset by the general and administrative expenses of $1,370,318.
For the six months ended June 30, 2022, we had net income of $795,204, which consists of change in fair value of warrant liabilities of $14,790,133 and interest income on cash and marketable securities held in the Trust Account of $664,129, offset by the general and administrative expenses of $4,759,361 and change in fair value of the Day one loss in derivative PIPE liability of $9,899,697.
For the three months ended June 30, 2021, we had net income of $3,110,277, which consists of the change in fair value of warrant liabilities of $3,749,867, and interest income on cash and marketable securities held in the Trust Account of $11,344, offset by general and administrative expenses of $650,934.
For the six months ended June 30, 2021, we had net income of $24,762,587, which consists of the change in fair value of warrant liabilities of $26,515.733, and interest income on cash and marketable securities held in the Trust Account of $163,505, offset by general and administrative expenses of $1,916,651.
Liquidity and Going Concern
On September 11, 2020, we consummated the Initial Public Offering of 82,800,000 Units, which includes the full exercise by the underwriters of their over- allotment option in the amount of 10,800,000 Units, at $10.00 per Unit, generating gross proceeds of $828,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 12,373,333 Private Placement Warrants at a price of $1.50 per warrant in a private placement to the Sponsor, generating gross proceeds of $18,560,000.
Following the Initial Public Offering, the exercise of the over-allotment option and the sale of the Private Placement Warrants, a total of $828,000,000 was placed in the Trust Account. We incurred $46,191,135 in transaction costs, including $16,560,000 of underwriting fees, $28,980,000 of deferred underwriting fees and $651,135 of other offering costs in connection with the Initial Public Offering and the sale of the Private Placement Warrants.
For the six months ended June 30, 2022, cash used in operating activities was $445,257. Net income of $795,204, was affected by interest earned on cash and marketable securities held in the Trust Account of $664,129 and a non-cash charge for the change in fair value of warrant liabilities of $14,790,133 and change in fair value of the Day one loss in derivative PIPE liability of $9,899,697. Changes in operating assets and liabilities provided $4,314,104 of cash for operating activities.
For the six months ended June 30, 2021, cash used in operating activities was $518,373. Net income of $24,762,587 was affected by the interest earned on cash and marketable securities held in the Trust Account of $163,505 and a non-cash charge for the change in fair value of warrant liabilities of $26,515,733. Changes in operating assets and liabilities provided $1,398,278 of cash for operating activities.
As of June 30, 2022, we had cash and marketable securities held in the Trust Account of $829,088,974 consisting of money market funds, which invest in money market funds that primarily invest in U.S. Treasury securities.
F-31